SuperworthMadrigal Pharmaceuticals shares outstanding MDGL
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 29.1M
- On a year earlier
- +3.2%
- more shares
Madrigal Pharmaceuticals had 29.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 22.9M | +5% |
| FY2024 | 21.9M | +11% |
| FY2023 | 19.8M | +15% |
| FY2022 | 17.2M | +1% |
| FY2021 | 17.1M | +10% |
| FY2020 | 15.5M | +0% |
| FY2019 | 15.4M | +1% |
| FY2018 | 15.3M | +22% |
| FY2017 | 12.6M | +9% |
| FY2016 | 11.5M | +193% |
| FY2015 | 3.9M | +27% |
| FY2014 | 3.1M | +41% |
| FY2013 | 2.2M | +22% |
| FY2012 | 1.8M | +27% |
| FY2011 | 1.4M | +20% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 29.1M | +3% | |
| Q1 FY26 | 29M | +3% | |
| Q4 FY25 | 22.9M | +5% | |
| Q3 FY25 | 22.5M | +3% | |
| Q2 FY25 | 28.2M | +32% | |
| Q1 FY25 | 28.1M | +40% | |
| Q4 FY24 | 21.9M | +11% | |
| Q3 FY24 | 21.7M | +18% | |
| Q2 FY24 | 21.4M | +17% | |
| Q1 FY24 | 20M | +10% | |
| Q4 FY23 | 19.8M | +15% | |
| Q3 FY23 | 18.5M | +8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Madrigal Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.